malignant neoplasia

FDA rejects piziotinib for certain types of NSCLC

FDA rejects piziotinib for certain types of NSCLC

The US Food and Drug Administration (FDA) has announced that it will not approve poziotinib (Spectrum Pharmaceuticals) for the treatment of certain patients with non-small cell lung cancer (NSCLC). The clinical data the company had submitted was deemed insufficient to approve, and further data, including a randomized clinical trial, would be needed, the agency said. …

FDA rejects piziotinib for certain types of NSCLC Read More »

Review of skin cancer in primary care: more harm than good

Review of skin cancer in primary care: more harm than good

Kenneth W. Lin, MD, MPH Hello everyone. I am Dr. Kenny Lin. I’m a family physician and Associate Director of Family Medicine Residency at Lancaster General Hospital, and I blog at Common Sense Family Doctor. An important part of my practice is adult health maintenance visits. Acknowledging the endless debate about the value of general …

Review of skin cancer in primary care: more harm than good Read More »